Statins were associated with a reduction in mortality but there was no significant difference in the composite end point with fenofibrates alone or in combination with statins.
Increased mortality risks were limited to the first post-HT year because increases in risks markedly decreased when the follow-up time was extended over more than 1 year.
Increases in BMI z-score between 7 and 13 years of age increase a person’s risk of ischemic stroke in early adulthood.
Hyperglycemia treatment was left to physician’s discretion.
Stroke risk with I-131 therapy for thyroid cancer was examined via 2 cohorts using 1:1 propensity score matching.
Pregnancy-associated stroke risk is even higher in women with chronic hypertension, coagulopathies, and prothrombotic conditions.
Patients with diabetes and both high triglycerides and low HDL-C have increased risks of incident coronary heart disease and stroke.
